Prostemics Co. Ltd (KQ:203690) — Market Cap & Net Worth

$1.88 Million USD · ₩2.78 Billion KRW · Rank #30125

Market Cap & Net Worth: Prostemics Co. Ltd (203690)

Prostemics Co. Ltd (KQ:203690) has a market capitalization of $1.88 Million (₩2.78 Billion) as of August 29, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #30125 globally and #2101 in its home market, demonstrating a 0.00% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Prostemics Co. Ltd's stock price ₩139.00 by its total outstanding shares 19989711 (19.99 Million). Check Prostemics Co. Ltd (203690) stock price for real-time trading data and today's change.

Prostemics Co. Ltd Market Cap History: 2015 to 2026

Prostemics Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $286.51 Million to $1.88 Million (-39.10% CAGR).

Index Memberships

Prostemics Co. Ltd is a constituent of 2 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
Kosdaq Composite Index KOSDAQ	$236.24 Billion	0.00%	#1151 of 1384
Kosdaq Composite Index KQ11	$236.24 Billion	0.00%	#1151 of 1384

Weight: Prostemics Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Prostemics Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Prostemics Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Prostemics Co. Ltd (203690) net assets to evaluate the company's book value and shareholders' equity.

Latest Price to Sales (P/S) Ratio

0.00x

Prostemics Co. Ltd's market cap is 0.00 times its annual revenue

Industry average: 5836.73x Lower than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$285.50 Million	$14.16 Billion	$4.31 Billion	0.02x	0.07x
2017	$484.30 Million	$6.56 Billion	-$3.16 Billion	0.07x	N/A
2018	$367.12 Million	$4.72 Billion	-$6.30 Billion	0.08x	N/A
2019	$236.39 Million	$7.13 Billion	-$3.18 Billion	0.03x	N/A
2020	$298.03 Million	$20.73 Billion	-$7.27 Billion	0.01x	N/A
2021	$186.61 Million	$32.53 Billion	-$7.24 Billion	0.01x	N/A
2022	$66.92 Million	$26.58 Billion	-$5.56 Billion	0.00x	N/A
2023	$137.63 Million	$37.25 Billion	-$24.24 Billion	0.00x	N/A
2024	$75.86 Million	$33.23 Billion	-$9.43 Billion	0.00x	N/A
2025	$59.94 Million	$16.08 Billion	-$11.80 Billion	0.00x	N/A

Competitor Companies of 203690 by Market Capitalization

Companies near Prostemics Co. Ltd in the global market cap rankings as of August 29, 2026. Also see Prostemics Co. Ltd (203690) cash conversion ratio for how efficiently the company converts equity into cash flow.

Key companies related to Prostemics Co. Ltd by market ranking:

Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #189 globally with a market cap of $130.90 Billion USD.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #335 globally with a market cap of $81.69 Billion USD.
CSL Ltd (AU:CSL): Ranked #459 globally with a market cap of $59.69 Billion USD ( AU$84.36 Billion AUD).
Samsung Biologics Co Ltd (KO:207940): Ranked #556 globally with a market cap of $50.00 Billion USD ( ₩73.79 Trillion KRW).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#189	Vertex Pharmaceuticals Inc	NASDAQ:VRTX	$130.90 Billion	$547.55
#335	Regeneron Pharmaceuticals Inc	NASDAQ:REGN	$81.69 Billion	$807.71
#459	CSL Ltd	AU:CSL	$59.69 Billion	AU$173.88
#556	Samsung Biologics Co Ltd	KO:207940	$50.00 Billion	₩1594000.00

Prostemics Co. Ltd Historical Marketcap From 2015 to 2026

Between 2015 and today, Prostemics Co. Ltd's market cap moved from $286.51 Million to $ 1.88 Million, with a yearly change of -39.10%.

Year	Market Cap	Change (%)
2026	₩1.88 Million	-96.86%
2025	₩59.94 Million	-20.98%
2024	₩75.86 Million	-44.88%
2023	₩137.63 Million	+105.67%
2022	₩66.92 Million	-64.14%
2021	₩186.61 Million	-37.39%
2020	₩298.03 Million	+26.07%
2019	₩236.39 Million	-35.61%
2018	₩367.12 Million	-24.20%
2017	₩484.30 Million	+69.63%
2016	₩285.50 Million	-0.35%
2015	₩286.51 Million	--

End of Day Market Cap According to Different Sources

On Aug 28th, 2026 the market cap of Prostemics Co. Ltd was reported to be:

Source	Market Cap
Yahoo Finance	$1.88 Million USD
MoneyControl	$1.88 Million USD
MarketWatch	$1.88 Million USD
marketcap.company	$1.88 Million USD
Reuters	$1.88 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Prostemics Co. Ltd

KQ:203690 Korea Biotechnology

Market Cap

$1.88 Million

₩2.78 Billion KRW

Market Cap Rank

#30125 Global

#2101 in Korea

Share Price

₩139.00

Change (1 day)

+0.00%

52-Week Range

₩139.00 - ₩139.00

All Time High

₩77250.00